Unlocking Asian Cell & Gene Innovation
Connecting Asia's advanced therapies ecosystem with global life science leaders
Partnerships • R&D • Investment • Technology • Regulatory
Global Pioneers in Cell and Gene Therapy: Driving Innovation, Manufacturing Excellence and Strategic Investment
Top Cell and Gene Therapy Companies Attending in 2026
What to Expect at Cell & Gene Therapy Summit 2026
+
Global leaders at the co-located ChinaBio Partnering Forum and Antibody & ADC Summit
+
Leading cell and gene therapy experts
+
Hours of networking with industry professionals
Your Roadmap to Advanced Therapies and Next-Gen Solutions: Agenda is Live
Step into the future of cell & gene therapies at the Cell & Gene Therapy Summit at ChinaBio®
Experience transformative discussions, groundbreaking research, and insights from visionary leaders. Explore how Asia’s advanced therapies ecosystem is reshaping partnerships, R&D, investment, technology, and regulatory frameworks to define the next era of cell and gene therapy.
A Decade of Expertise, Now in China: Cell & Gene Therapy Summit 2026
With over a decade of experience hosting premier cell and gene therapy events in the US and Europe, attracting 1,500+ attendees annually, Cell & Gene Therapy International is bringing its expertise to China. The 2026 summit in Shanghai is designed to foster collaboration among top researchers, biopharmaceutical leaders, and industry pioneers, with a focus on cutting-edge R&D, manufacturing excellence, and strategic partnerships. Attendees will gain unparalleled insights into breakthrough methodologies across cell therapies, gene editing platforms, viral vector technologies, and the discovery-to-clinic continuum—empowering them to drive innovation and growth in the China market.
Mapping the Road from Cutting-Edge Discoveries to Commercial Success
Explore the key themes shaping Cell & Gene Therapies Summit 2026, designed to help you navigate the entire lifecycle of CGT development
Achieve Funding Success: Align with Global Pharma and Investor Priorities
Gain a competitive advantage by uncovering what global investors and big pharma seek in cell and gene therapy products and enabling technologies to secure your next opportunity
R&D Innovations: Explore the Future of Cell and Gene Therapy
Discover cutting-edge R&D developments including, in vivo CAR-T, solid tumours, and new therapeutic modalities expanding treatments to broader populations
Master Manufacturing Scale-Up
Unlock actionable insights from real-world case studies to enhance manufacturing efficiency and reduce costs for autologous, allogeneic, and AAV therapies
Optimise Processes with AI and Automation
Leverage AI, automation, robotics and novel technologies for faster, smarter production
Navigate the Global Regulatory Landscape
Attain clarity on USA, EU, and China frameworks to accelerate approvals worldwide
From Lab to Launch: Succeed in China’s CGT Market
Explore effective strategies to move from clinical development to market launch
Beyond the Session Room
It’s not just about the talks. From coffee breaks to networking receptions, every moment is designed to spark connections, collaborations, and new business opportunities.
Exhibit Hall
Step into the showcase of innovation. Explore the latest tools, platforms, and solutions in manufacturing, analytics, and clinical development with a spotlight on technologies shaping China’s biotech market.
Panel Discussions: Your Questions, Answered
Curious about navigating China’s funding landscape or unlocking partnerships with big pharma? Our keynote panels bring investors and industry leaders together to tackle the questions that matter most.
partneringONE™: Strategic Networking Made Simple
Plan smarter, connect faster. partneringONE™ helps you identify the right people, schedule targeted 1:1 meetings, and turn introductions into lasting collaborations.
Co-Located with ChinaBio® Partnering Forum and Antibody & ADC Innovation Summit
Your Cell and Gene Therapy Summit registration unlocks full access to two additional powerhouse events. Together, they draw 1,000+ scientists, executives, and investors - creating a unique ecosystem where science, strategy, and partnerships thrive in the heart of China’s biotech boom.
China: The Rising Powerhouse of Cell & Gene Therapy Innovation
Optimise your go-to-market strategies by connecting face-to-face with China's leading biopharma executives, regulatory authorities, and research pioneers shaping the future of cell and gene therapy
Unparalleled Market Growth
Home to 1,000+ cell and gene therapy developers across Asia-Pacific, with China's CGT market projected to reach $4 billion by 2027, establishing the region as a global industry powerhouse.
Robust Clinical Development
With over 1,000 active cell and gene therapy clinical trials in China alone, offering unprecedented access to innovation pipelines and research partnerships.
Breakthrough Regulatory Milestones
China's landmark 2025 approvals—including its first mesenchymal stem cell therapy and first gene editing product to receive FDA RMAT designation—showcase the country's accelerating regulatory framework.
Engage a qualified audience of global cell and gene therapy executives and scientists!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals.
Contact Roshni Shah to learn more about sponsorship opportunities: RShah@informaconnectls.com
Related Events
FAQs
What is the Cell & Gene Therapy Summit at ChinaBio®?
The Cell & Gene Therapy Summit at ChinaBio® is a leading international conference focused on advanced therapies, bringing together global and Asian leaders in cell therapy, gene therapy, manufacturing, investment, and regulation to drive collaboration and innovation in China’s biotech ecosystem.
When and where does the Cell & Gene Therapy Summit at ChinaBio® take place?
The event takes place April 28–29, 2026, at the Kerry Hotel Pudong, Shanghai, China.
Who should attend the Cell & Gene Therapy Summit at ChinaBio®?
The summit is designed for biotech and pharma executives, cell and gene therapy developers, R&D leaders, manufacturing experts, investors, regulators, technology providers, and business development professionals looking to engage with China’s advanced therapies market.
What topics are covered at the Cell & Gene Therapy Summit?
Key topics include CAR-T and in vivo cell therapies, gene editing, RNA-based therapeutics, manufacturing scale-up, automation and AI, regulatory strategy, clinical development, investment trends, and partnerships across the cell and gene therapy value chain.
What types of sessions are included in the agenda?
The agenda features keynote presentations, panel discussions, case studies, sponsored scientific tracks, and technology spotlight sessions focused on real-world challenges and solutions in cell and gene therapy development and commercialization.
Who are the speakers at the Cell & Gene Therapy Summit at ChinaBio®?
Speakers include senior leaders from global and Chinese biotech and pharma companies, investors, and regulatory experts, such as executives from Orchard Therapeutics, Atara Biotherapeutics, FosunKairos, JW Therapeutics, Sangamo Therapeutics, and leading venture capital firms.
How does the summit support networking and partnering?
Attendees gain access to partneringONE™, a powerful networking platform that enables participants to identify relevant contacts, schedule 1:1 meetings, and maximize business development opportunities before and during the event.
Is the Cell & Gene Therapy Summit co-located with other events?
Yes. The summit is co-located with the ChinaBio® Partnering Forum and the Antibody & ADC Innovation Summit, giving attendees access to a broader ecosystem of more than 1200 global scientists, executives, and investors.
Does one registration provide access to multiple events?
Yes. Registration for the Cell & Gene Therapy Summit at ChinaBio® includes full access to the co-located ChinaBio® Partnering Forum and Antibody & ADC Innovation Summit.
What networking opportunities are available onsite?
Networking opportunities include structured 1:1 partnering meetings, coffee breaks, networking receptions, exhibition hall interactions, and informal discussions designed to spark collaborations and deal-making.
What is the exhibition hall focused on?
The exhibition hall showcases innovative tools, platforms, and solutions in manufacturing, analytics, automation, and clinical development, with a strong focus on technologies shaping China’s biotech and cell and gene therapy market.
Does the event cover regulatory strategy for China?
Yes. Multiple sessions address global and Chinese regulatory pathways, including NMPA requirements, CMC reviews, inspections, fast-track pathways, and best practices for successful submissions in China.
Are there opportunities to speak at the Cell & Gene Therapy Summit?
Yes. Companies and experts interested in speaking opportunities can contact the event team to discuss participation in keynote sessions, panels, case studies, or sponsored scientific tracks.
Are sponsorship and exhibition opportunities available?
Yes. The event offers a range of sponsorship, exhibition, and custom partnership opportunities to help organizations increase visibility, launch products, and connect with qualified decision-makers in the cell and gene therapy space.
How many attendees are expected at the event?
The co-located events collectively attract 1,200+ global leaders, including biotech executives, investors, and scientific experts, creating a high-impact environment for networking and collaboration.
What makes the Cell & Gene Therapy Summit at ChinaBio® unique?
The summit uniquely connects Asia’s advanced therapies ecosystem with global life science leaders, combining scientific depth, investment insight, regulatory expertise, and partnering opportunities in one of the world’s fastest-growing biotech markets.